Collectively, the findings summarized in this section suggest that people carrying the certain variants of human GC-A gene are more susceptible to cardiovascular diseases such as hypertension and cardiac hypertrophy than those who do not, possibly because they are resistant to the counter-regulation of Gαq signaling by ANP/BNP (Fig. (6)). Here, NPPA is linked to hypertensive disorder.